设计以分泌IFNκ的CAR T细胞通过IFNAR/STAT1/ACSL4轴诱导瘤铁亡
Yaoxin Gao1, Shasha Liu1, Yifan Huang1
1Biotherapy Center and Cancer Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Cancer immunology research
|August 27, 2024
概括
干扰素卡帕 (IFNκ) 增强瘤细胞铁亡,增强仿真抗原受体 (CAR) T细胞治疗的有效性. 这种细胞因子诱导免疫细胞死亡,改善CAR T细胞抗瘤活性在体外和体内.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 细胞死亡机制 细胞死亡机制
背景情况:
- 铁,一种依赖于铁的细胞死亡,影响癌症免疫力.
- 调节铁亡是一种改善癌症治疗的策略,包括CAR T细胞疗法.
研究的目的:
- 为了研究干扰因子卡帕 (IFNκ) 在ferroptosis诱导中的作用.
- 评估IFNκ提高CAR T细胞治疗疗效的潜力.
主要方法:
- 评估了IFNκ对瘤细胞对ferroptosis诱导剂 (埃拉斯,阿拉基酸) 敏感性的影响.
- 通过IFNAR/STAT1/ACSL4轴阐明了IFNκ诱导的铁亡的分子机制.
- 改造了CAR T细胞以表达IFNκ,并试验了它们的抗瘤活性在体外和体内.
主要成果:
- IFNκ增强了瘤细胞对铁亡的敏感性.
- 通过IFNAR/STAT1/ACSL4途径,IFNκ结合阿拉基酸诱导免疫性瘤铁死.
- 经IFNκ工程改造的CAR T细胞对抗原阳性和阴性瘤细胞的抗瘤效率有所提高.
结论:
- IFNκ可以被利用来诱导瘤铁亡.
- 作为一种细胞因子,IFNκ有潜力增强CAR T细胞的抗瘤功能.
相关概念视频
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
01:27Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861
02:26NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K